Mammalian expression is the system of choice for studying the function of a particular protein in the most physiologically relevant environment, because it allows for the highest level of posttranslational processing and functional activity of the protein.
The global market for Mammalian Protein Expression was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 311%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mammalian Protein Expression, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Mammalian Protein Expression by region & country, by Type, and by Application.
The Mammalian Protein Expression market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mammalian Protein Expression.
麻豆原创 Segmentation
By Company
Thermo Fisher
Evitria
Kemp Protein
ProMab Biotechnologies
Sartorius
OriGene
Lonza
GenScript
Biointron
ProteoGenix
ABclonal Technology
Gene Universal
Rapid Novor
Synbio Technologies
LPS-BioSciences
Takara Bio
Sino Biological
Abace Biotechnology
Zoonbio Biotechnology
Merck
General Biol
Beijing Protein Innovation
Hangzhou Clongene Biotech
Detai Bio
NovoPro
Segment by Type:
Membrane Protein
Nucleoprotein
Intracellular Protein
Secretory Protein
Others
Segment by Application
Protein Drugs Development
Biologial Experiment
Diagnostic Development
Antibody Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mammalian Protein Expression manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Mammalian Protein Expression in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Mammalian Protein Expression in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Mammalian Protein Expression Product Introduction
1.2 Global Mammalian Protein Expression 麻豆原创 Size Forecast
1.3 Mammalian Protein Expression 麻豆原创 Trends & Drivers
1.3.1 Mammalian Protein Expression Industry Trends
1.3.2 Mammalian Protein Expression 麻豆原创 Drivers & Opportunity
1.3.3 Mammalian Protein Expression 麻豆原创 Challenges
1.3.4 Mammalian Protein Expression 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mammalian Protein Expression Players Revenue Ranking (2023)
2.2 Global Mammalian Protein Expression Revenue by Company (2019-2024)
2.3 Key Companies Mammalian Protein Expression Manufacturing Base Distribution and Headquarters
2.4 Key Companies Mammalian Protein Expression Product Offered
2.5 Key Companies Time to Begin Mass Production of Mammalian Protein Expression
2.6 Mammalian Protein Expression 麻豆原创 Competitive Analysis
2.6.1 Mammalian Protein Expression 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Mammalian Protein Expression Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian Protein Expression as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Membrane Protein
3.1.2 Nucleoprotein
3.1.3 Intracellular Protein
3.1.4 Secretory Protein
3.1.5 Others
3.2 Global Mammalian Protein Expression Sales Value by Type
3.2.1 Global Mammalian Protein Expression Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mammalian Protein Expression Sales Value, by Type (2019-2030)
3.2.3 Global Mammalian Protein Expression Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Protein Drugs Development
4.1.2 Biologial Experiment
4.1.3 Diagnostic Development
4.1.4 Antibody Development
4.1.5 Others
4.2 Global Mammalian Protein Expression Sales Value by Application
4.2.1 Global Mammalian Protein Expression Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mammalian Protein Expression Sales Value, by Application (2019-2030)
4.2.3 Global Mammalian Protein Expression Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Mammalian Protein Expression Sales Value by Region
5.1.1 Global Mammalian Protein Expression Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mammalian Protein Expression Sales Value by Region (2019-2024)
5.1.3 Global Mammalian Protein Expression Sales Value by Region (2025-2030)
5.1.4 Global Mammalian Protein Expression Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Mammalian Protein Expression Sales Value, 2019-2030
5.2.2 North America Mammalian Protein Expression Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Mammalian Protein Expression Sales Value, 2019-2030
5.3.2 Europe Mammalian Protein Expression Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Mammalian Protein Expression Sales Value, 2019-2030
5.4.2 Asia Pacific Mammalian Protein Expression Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Mammalian Protein Expression Sales Value, 2019-2030
5.5.2 South America Mammalian Protein Expression Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Mammalian Protein Expression Sales Value, 2019-2030
5.6.2 Middle East & Africa Mammalian Protein Expression Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mammalian Protein Expression Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mammalian Protein Expression Sales Value
6.3 United States
6.3.1 United States Mammalian Protein Expression Sales Value, 2019-2030
6.3.2 United States Mammalian Protein Expression Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mammalian Protein Expression Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mammalian Protein Expression Sales Value, 2019-2030
6.4.2 Europe Mammalian Protein Expression Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mammalian Protein Expression Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mammalian Protein Expression Sales Value, 2019-2030
6.5.2 China Mammalian Protein Expression Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mammalian Protein Expression Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mammalian Protein Expression Sales Value, 2019-2030
6.6.2 Japan Mammalian Protein Expression Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mammalian Protein Expression Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mammalian Protein Expression Sales Value, 2019-2030
6.7.2 South Korea Mammalian Protein Expression Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mammalian Protein Expression Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mammalian Protein Expression Sales Value, 2019-2030
6.8.2 Southeast Asia Mammalian Protein Expression Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mammalian Protein Expression Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mammalian Protein Expression Sales Value, 2019-2030
6.9.2 India Mammalian Protein Expression Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mammalian Protein Expression Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Profile
7.1.2 Thermo Fisher Main Business
7.1.3 Thermo Fisher Mammalian Protein Expression Products, Services and Solutions
7.1.4 Thermo Fisher Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Recent Developments
7.2 Evitria
7.2.1 Evitria Profile
7.2.2 Evitria Main Business
7.2.3 Evitria Mammalian Protein Expression Products, Services and Solutions
7.2.4 Evitria Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.2.5 Evitria Recent Developments
7.3 Kemp Protein
7.3.1 Kemp Protein Profile
7.3.2 Kemp Protein Main Business
7.3.3 Kemp Protein Mammalian Protein Expression Products, Services and Solutions
7.3.4 Kemp Protein Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.3.5 ProMab Biotechnologies Recent Developments
7.4 ProMab Biotechnologies
7.4.1 ProMab Biotechnologies Profile
7.4.2 ProMab Biotechnologies Main Business
7.4.3 ProMab Biotechnologies Mammalian Protein Expression Products, Services and Solutions
7.4.4 ProMab Biotechnologies Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.4.5 ProMab Biotechnologies Recent Developments
7.5 Sartorius
7.5.1 Sartorius Profile
7.5.2 Sartorius Main Business
7.5.3 Sartorius Mammalian Protein Expression Products, Services and Solutions
7.5.4 Sartorius Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.5.5 Sartorius Recent Developments
7.6 OriGene
7.6.1 OriGene Profile
7.6.2 OriGene Main Business
7.6.3 OriGene Mammalian Protein Expression Products, Services and Solutions
7.6.4 OriGene Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.6.5 OriGene Recent Developments
7.7 Lonza
7.7.1 Lonza Profile
7.7.2 Lonza Main Business
7.7.3 Lonza Mammalian Protein Expression Products, Services and Solutions
7.7.4 Lonza Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.7.5 Lonza Recent Developments
7.8 GenScript
7.8.1 GenScript Profile
7.8.2 GenScript Main Business
7.8.3 GenScript Mammalian Protein Expression Products, Services and Solutions
7.8.4 GenScript Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.8.5 GenScript Recent Developments
7.9 Biointron
7.9.1 Biointron Profile
7.9.2 Biointron Main Business
7.9.3 Biointron Mammalian Protein Expression Products, Services and Solutions
7.9.4 Biointron Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.9.5 Biointron Recent Developments
7.10 ProteoGenix
7.10.1 ProteoGenix Profile
7.10.2 ProteoGenix Main Business
7.10.3 ProteoGenix Mammalian Protein Expression Products, Services and Solutions
7.10.4 ProteoGenix Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.10.5 ProteoGenix Recent Developments
7.11 ABclonal Technology
7.11.1 ABclonal Technology Profile
7.11.2 ABclonal Technology Main Business
7.11.3 ABclonal Technology Mammalian Protein Expression Products, Services and Solutions
7.11.4 ABclonal Technology Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.11.5 ABclonal Technology Recent Developments
7.12 Gene Universal
7.12.1 Gene Universal Profile
7.12.2 Gene Universal Main Business
7.12.3 Gene Universal Mammalian Protein Expression Products, Services and Solutions
7.12.4 Gene Universal Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.12.5 Gene Universal Recent Developments
7.13 Rapid Novor
7.13.1 Rapid Novor Profile
7.13.2 Rapid Novor Main Business
7.13.3 Rapid Novor Mammalian Protein Expression Products, Services and Solutions
7.13.4 Rapid Novor Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.13.5 Rapid Novor Recent Developments
7.14 Synbio Technologies
7.14.1 Synbio Technologies Profile
7.14.2 Synbio Technologies Main Business
7.14.3 Synbio Technologies Mammalian Protein Expression Products, Services and Solutions
7.14.4 Synbio Technologies Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.14.5 Synbio Technologies Recent Developments
7.15 LPS-BioSciences
7.15.1 LPS-BioSciences Profile
7.15.2 LPS-BioSciences Main Business
7.15.3 LPS-BioSciences Mammalian Protein Expression Products, Services and Solutions
7.15.4 LPS-BioSciences Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.15.5 LPS-BioSciences Recent Developments
7.16 Takara Bio
7.16.1 Takara Bio Profile
7.16.2 Takara Bio Main Business
7.16.3 Takara Bio Mammalian Protein Expression Products, Services and Solutions
7.16.4 Takara Bio Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.16.5 Takara Bio Recent Developments
7.17 Sino Biological
7.17.1 Sino Biological Profile
7.17.2 Sino Biological Main Business
7.17.3 Sino Biological Mammalian Protein Expression Products, Services and Solutions
7.17.4 Sino Biological Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.17.5 Sino Biological Recent Developments
7.18 Abace Biotechnology
7.18.1 Abace Biotechnology Profile
7.18.2 Abace Biotechnology Main Business
7.18.3 Abace Biotechnology Mammalian Protein Expression Products, Services and Solutions
7.18.4 Abace Biotechnology Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.18.5 Abace Biotechnology Recent Developments
7.19 Zoonbio Biotechnology
7.19.1 Zoonbio Biotechnology Profile
7.19.2 Zoonbio Biotechnology Main Business
7.19.3 Zoonbio Biotechnology Mammalian Protein Expression Products, Services and Solutions
7.19.4 Zoonbio Biotechnology Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.19.5 Zoonbio Biotechnology Recent Developments
7.20 Merck
7.20.1 Merck Profile
7.20.2 Merck Main Business
7.20.3 Merck Mammalian Protein Expression Products, Services and Solutions
7.20.4 Merck Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.20.5 Merck Recent Developments
7.21 General Biol
7.21.1 General Biol Profile
7.21.2 General Biol Main Business
7.21.3 General Biol Mammalian Protein Expression Products, Services and Solutions
7.21.4 General Biol Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.21.5 General Biol Recent Developments
7.22 Beijing Protein Innovation
7.22.1 Beijing Protein Innovation Profile
7.22.2 Beijing Protein Innovation Main Business
7.22.3 Beijing Protein Innovation Mammalian Protein Expression Products, Services and Solutions
7.22.4 Beijing Protein Innovation Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.22.5 Beijing Protein Innovation Recent Developments
7.23 Hangzhou Clongene Biotech
7.23.1 Hangzhou Clongene Biotech Profile
7.23.2 Hangzhou Clongene Biotech Main Business
7.23.3 Hangzhou Clongene Biotech Mammalian Protein Expression Products, Services and Solutions
7.23.4 Hangzhou Clongene Biotech Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.23.5 Hangzhou Clongene Biotech Recent Developments
7.24 Detai Bio
7.24.1 Detai Bio Profile
7.24.2 Detai Bio Main Business
7.24.3 Detai Bio Mammalian Protein Expression Products, Services and Solutions
7.24.4 Detai Bio Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.24.5 Detai Bio Recent Developments
7.25 NovoPro
7.25.1 NovoPro Profile
7.25.2 NovoPro Main Business
7.25.3 NovoPro Mammalian Protein Expression Products, Services and Solutions
7.25.4 NovoPro Mammalian Protein Expression Revenue (US$ Million) & (2019-2024)
7.25.5 NovoPro Recent Developments
8 Industry Chain Analysis
8.1 Mammalian Protein Expression Industrial Chain
8.2 Mammalian Protein Expression Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mammalian Protein Expression Sales Model
8.5.2 Sales Channel
8.5.3 Mammalian Protein Expression Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Thermo Fisher
Evitria
Kemp Protein
ProMab Biotechnologies
Sartorius
OriGene
Lonza
GenScript
Biointron
ProteoGenix
ABclonal Technology
Gene Universal
Rapid Novor
Synbio Technologies
LPS-BioSciences
Takara Bio
Sino Biological
Abace Biotechnology
Zoonbio Biotechnology
Merck
General Biol
Beijing Protein Innovation
Hangzhou Clongene Biotech
Detai Bio
NovoPro
听
听
*If Applicable.